Trial NCT02254551

View at ClinicalTrials.gov 
Org. Study IDs: SCRI MM 50

Last trial update was posted on 2017-02-16

MeSH Interventions

Bortezomib

MeSH Conditions

Multiple Myeloma Neoplasms, Plasma Cell

Other Conditions


Stopping Reasons

Safety lead-in data did not support continuation of study.

Limitations And Caveats

Early termination of study during dose-escalation did not support continuation of study.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID